Business definitions for young people drug and alcohol treatment providers to input data onto the national drug treatment monitoring system (NDTMS)
Bibliography: All Publications
Balancing Treaty Stability and Change (PDF)
Inter se modification of the UN drug control conventions to facilitate cannabis regulation (GDPO)
Wastewater analysis and drugs — a European multi-city study (Perspectives on drugs)
The findings of the largest European project to date in the emerging science of wastewater analysis are taken up in this ‘Perspective on drugs’ (EMCDDA)
The Death Penalty for Drug Offences
Global Overview 2017 (HRI)
The misuse of synthetic opioids (PDF)
harms and clinical management of fentanyl, fentanyl analogues and other novel synthetic opioids Information for clinicians (NEPTUNE group)
Our Invisible Addicts (2nd edition)
This report, which has been developed with representation from a patient, the Royal College of Psychiatrists, the Royal College of General Practitioners and the British Geriatrics Society, provides the latest milestone on the journey towards developing the best possible response to this important problem
Implementing Supervised Injection Services (PDF)
This nursing best practice guideline (BPG) is a comprehensive document that provides an overview of principles, resources, and structures for delivering evidence-based supervised injection services (Registered Nurses’ Association of Ontario)
Government response to ACMD Report (PDF)
Commissioning impact on drug treatment services ( Department of Health and Social Care)
Alcohol and drug misuse prevention and treatment guidance – updated
Information and other resources to support commissioners, service providers and others providing alcohol and drug interventions (Public Health England)
Environmental substance use prevention interventions in Europe
This report provides an overview of the range of environmental prevention interventions used in the substance use field and, based on a survey of prevention experts, paints a first picture of the extent to which environmental prevention measures are currently used in Europe as a starting point for future research (EMCDDA)
Homeless adults with complex needs: evidence review
Overview of the homeless situation across England with insights into the current evidence base to support action to prevent and reduce homelessness (Public Health England)
Fentanyl Overdose Reduction Checking Analysis Study (PDF)
FORECAST had three phases, conducted between April 2017 and November 2017: (1) evaluating drug checking technologies; (2) interviewing people who use drugs; and (3) interviewing key informants from organizations that work with people who use drugs (John Hopkins University – Bloomberg American Health Initiative)
Link Between Medical Marijuana and Fewer Opioid Deaths Is More Complex Than Previously Reported
The association between medical marijuana and lower levels of opioid overdose deaths—identified previously in several studies—is more complex than previously described and appears to be changing as both medical marijuana laws and the opioid crisis evolve, according to a new RAND Corporation study
Programming document 2018–20
he EMCDDA Programming Document for the period 2018–20 covers the final year of implementation of the EMCDDA Strategy 2016–18 and coincides with the completion of the first Roadmap established under the new EMCDDA Strategy 2025
Statistics on Drug Misuse, England 2018
Presents a range of information on drug use by adults and children drawn together from a variety of sources. (NHS Digital)
Costs and unintended consequences of drug control policies (PDF)
Report by the expert group on possible adverse effects and associated costs of drug control policies (Pompidou Group)
Counternarcotics – Afghanistan (PDF)
SIGAR’s quarterly report to US Congress
Substance misuse treatment in secure settings: statistics 2016 to 2017
Alcohol and drug misuse treatment in prisons and other secure settings from PHE’s national drug treatment monitoring system (NDTMS)
What we learned about alcohol and drug treatment in prisons from the 2016-17 statistics
The report is only the second of its kind meaning it’s too early to see trends but we can compare to the previous year. Below is a summary of the main points from this year’s numbers: (Public Health England)
Measuring the ‘world drug problem’: ARQ Revision.
Beyond traditional indicators? (GDPO)
- « Previous Page
- 1
- …
- 44
- 45
- 46
- 47
- 48
- …
- 97
- Next Page »